Transcatheter Cardiovascular Therapeutics (TCT) 2020

Lower Bleeding Risk with Post-PCI Bivalirudin in Heart Attack Patients

Lower Bleeding Risk with Post-PCI Bivalirudin in Heart Attack Patients: Analysis

Bivalirudin yielded similar 30-day mortality rates to heparin following percutaneous coronary intervention (PCI) in heart attack patients, but showed...
Novel Fixed-Wire DES Does Not Achieve Non-Inferiority vs. Existing Stents

OPTIMIZE: Novel Fixed-Wire Drug-Eluting Stent Does Not Achieve Non-Inferiority Compared to Existing Systems

New findings presented at Transcatheter Cardiovascular Therapeutics (TCT) 2020 showed that the Slender Integrated Delivery System (IDS), a novel,...
Second TAVR Procedure Safe, Effective Treatment for Valve Degeneration

TRANSIT: Second TAVR Procedure Safe and Effective Treatment for Valve Degeneration

A second transcatheter procedure may safely and effectively treat patients with degenerated bioprostheses following transcatheter aortic valve replacement (TAVR),...
COBRA-REDUCE: Cobra PzF Stent Fails to Best DES

COBRA-REDUCE: Cobra PzF Stent Fails to Best DES

A novel NanoCoated Coronary Stent (NCS) failed to meet noninferiority criteria to a drug eluting stent, new trial results...
Self-Expandable vs. Balloon-Expandable Valves Yield Similar Outcomes

SOLVE-TAVI: Self-Expandable vs. Balloon-Expandable Valves Yield Similar Outcomes

Two different types of prosthetic aortic valves yielded similar rates of mortality, valve regurgitation, and need for subsequent pacemaker...
Outcomes of PCI Deferral in FFR-Abnormal Lesions with Intact CFR

DEFINE-FLOW: Assessing Clinical Outcomes of PCI Deferral in FFR-Abnormal Lesions with Intact CFR

Results from a new observational study presented at Transcatheter Cardiovascular Therapeutics (TCT) 2020 showed that untreated lesions with abnormal...
FORECAST: Computerized FFR Management Effective, But Fails to Reduce Costs

FORECAST: Computerized FFR Management Effective, But Fails to Reduce Costs

New research presented at Transcatheter Cardiovascular Therapeutics (TCT) 2020 showed that while fractional flow reserve management derived from computed...
TARGET FFR: Optimization Strategy Doesn't Raise Post-PCI FFR

TARGET FFR: Optimization Strategy Doesn’t Raise Post-PCI FFR

Physiologically-guided percutaneous coronary intervention (PCI) lowered the proportion of patients with lower residual fractional flow reserve (FFR), but failed...
COBRA-REDUCE: Cobra PzF Stent Fails to Best DES

Intravascular Lithotripsy Safely Facilitates Stent Implantation Involving Severe Coronary Calcification

New research presented at Transcatheter Cardiovascular Therapeutics (TCT) 2020 showed that coronary intravascular lithotripsy (IVL) safely and effectively enabled...
MITHRAS: Atrial Septal Defect Closure After Mitral Valve Repair

MITHRAS: Atrial Septal Defect Closure After Mitral Valve Repair

Interventional closure of iatrogenic atrial septal defect (iASD) with transcatheter mitral valve repair was not superior to regular medical...
PROSPECT ABSORB: BVS Plus GDMT Safe and Effective Intervention for Vulnerable Plaque

PROSPECT ABSORB: BVS Plus GDMT Safe and Effective Intervention for Vulnerable Plaque

Percutaneous coronary intervention (PCI) with a bioresorbable vascular scaffold (BVS) in mild non-flow-limiting lesions with large plaque burden was...
DEFINE-PCI: One Year Outcomes in Post-PCI Patients with Residual Ischemia

DEFINE-PCI: One Year Outcomes in Post-PCI Patients with Residual Ischemia

Despite successful percutaneous coronary intervention (PCI), symptomatic patients without residual ischemia improved more than those with it, new one-year...
OCT-FFR: Combined Techniques Improve Plaque ID in Diabetics

COMBINE OCT-FFR: Combined Techniques Improve Plaque Identification in Diabetics

The use of fractional flow reserve (FFR) combined with optical coherence tomography (OCT) improves the accuracy of high-risk lesion...
COMPARE CRUSH: Integral and Crushed Pills Same for TIMI Flow Post-PCI

COMPARE CRUSH: Integral and Crushed Pills Same for TIMI Flow Post-PCI

Crushing prasugrel tablets does not improve TIMI 3 flow in the time just after primary percutaneous coronary intervention (PCI),...